China Universal Asset Management Company’s Trevi Therapeutics TRVI Stock Holding History

China Universal Asset Management Company’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$433K	Sell	23,196 -9,559	-29%	-$139K	0.03%	276
2026 Q1	$391K	Buy	32,755 +11,860	+57%	+$133K	0.03%	283
2025 Q4	$262K	Sell	20,895 -451	-2%	-$5.21K	0.02%	319
2025 Q3	$195K	Buy	21,346 +911	+4%	+$6.83K	0.02%	338
2025 Q2	$112K	Buy	20,435 +2,510	+14%	+$15.6K	0.01%	358
2025 Q1	$113K	Buy	17,925 +1,627	+10%	+$7.76K	0.01%	353
2024 Q4	$67.1K	Buy	+16,298	New	+$52.2K	0.01%	431

Other funds holding TRVI

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

TCOT

Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

PFS Partners Mine Hill, New Jersey $247M AUM 29.02% 1-Year Est. Return

ZCP

Z3 Capital Partners Richmond, Virginia $476M AUM

HCA

Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company's TRVI Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Trevi Therapeutics (TRVI) stake by 29% in Q2 2026, selling an estimated $139K and leaving 23,196 shares worth $433K. The position accounts for 0.03% of the portfolio, ranked #276.

China Universal Asset Management Company first reported a position in TRVI in Q4 2024 and has held it in 7 quarters since. 30 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

China Universal Asset Management Company held 23,196 shares of Trevi Therapeutics worth $433K as of Q2 2026.
China Universal Asset Management Company sold 9,559 Trevi Therapeutics shares in Q2 2026, an estimated $139K.
Trevi Therapeutics made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #276 holding.
China Universal Asset Management Company first reported a position in Trevi Therapeutics in Q4 2024 and has held it in 7 quarters since.
30 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.